Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Jenevieve Nutovits

ID: 1b83a685-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

FDA Approves New Dose for Celltrion’s OMLYCLO (omalizumab-igec)

Big Molecule Watch · December 18, 2025

FDA Accepts BLA for Amneal’s Denosumab Biosimilars

Big Molecule Watch · March 12, 2025

FDA Accepts BLA for Shanghai Henlius Biotech’s HLX11, a Pertuzumab Biosimilar

Big Molecule Watch · February 6, 2025

Teva and mAbxience Add Additional Oncology Biosimilar Candidate, Expanding Strategic Partnership

Big Molecule Watch · October 16, 2024

Update on Recent International Biosimilar Approvals

Big Molecule Watch · September 26, 2023

Previous

12 3

Next

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog